<p>The present invention provides the gene CINP (cyclin-dependent kinase 2-interacting protein) as marker for predicting the response of a cancer patient to EGFR inhibitor treatment.</p>
申请公布号
WO2010015535(A1)
申请公布日期
2010.02.11
申请号
WO2009EP59633
申请日期
2009.07.27
申请人
F. HOFFMANN-LA ROCHE AG;DELMAR, PAUL;DELORD, JEAN-PIERRE;ROCHAIX, PHILIPPE;THOMAS, FABIENNE
